Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/8498
Title: | Formulation Development and Optimization of Transungual Drug Delivery System of Terbinafine Hydrochloride for the Treatment of Onychomycosis |
Keywords: | Nail lacquer Bovine hoof membranes Drug permeation Ex vivo antifungal activity Onychomycosis |
Issue Date: | 2016 |
Publisher: | Taylor and Francis |
Series/Report no.: | IPFP0341; |
Abstract: | The aim of present investigation was to develop transungual drug delivery system (nail lacquer) of terbinafine hydrochloride for treatment of onychomycosis. Different types of penetration enhancers, viz. 2-mercaptoethanol, n-acetyl- L-cysteine and thioglycolic acid, were evaluated to determine their effect on drug permeation. Various types of polymers, both hydrophobic (Eudragit® RL 100 and Eudragit® RS 100) and hydrophilic polymers (hydroxypropyl methyl cellulose (HPMC) E15), were evaluated for their film-forming and drug permeation characteristics. The nail lacquer was optimised statistically by applying 32 full factorial design. Polymer ratio (Eudragit® RL 100/HPMC E15; X1) and solvent ratio (ethanol/water; X2) were selected as independent variable, and viscosity (cPs), nail plate hydration (%) and in vitro drug permeated at the end of 24 h (μg/cm2) were selected as dependent variable. The optimised batch comprises of polymer ratio (70:30) and solvent ratio (75:25). Ex vivo drug permeation study was performed using human cadaver toe nail plate. The results revealed that the amount of drug permeated at the end of 24 h was 61.55 ± 3.2 μg/cm2, which was found to be higher than the minimum inhibitory concentration of drug. This study confirms that the developed drug-loaded nail lacquer could be used as a promising tool for the effective treatment of onychomycosis. |
Description: | Expert Opinion on Drug Delivery; March 2016:771-775 |
URI: | http://10.1.7.192:80/jspui/handle/123456789/8498 |
Appears in Collections: | Faculty Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IPFP0341.pdf | IPFP0341 | 3.98 MB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.